The P3 Event-Related Potential is a Biomarker for the Efficacy of Vagus Nerve Stimulation in Patients with Epilepsy

Neurotherapeutics

Volumn 11, Issue 3, 2014, Pages 612-622

  De Taeye, Leen ^a   Vonck, Kristl ^a   van Bochove, Marlies ^a   Boon, Paul ^a   Van Roost, Dirk ^b   Mollet, Lies ^a   Meurs, Alfred ^a   De Herdt, Veerle ^a   Carrette, Evelien ^a   Dauwe, Ine ^a   Gadeyne, Stefanie ^a   van Mierlo, Pieter ^a   Verguts, Tom ^a   Raedt, Robrecht ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

biomarker; epilepsy; event related potentials; norepinephrine; P3; Vagus nerve stimulation

Indexed keywords

BIOLOGICAL MARKER; NORADRENALIN;

ADULT; AMPLITUDE MODULATION; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CLINICAL ARTICLE; EPILEPSY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; LOCUS CERULEUS; MALE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; SEIZURE; TREATMENT RESPONSE; VAGUS NERVE STIMULATION; BRAIN CORTEX; ELECTROENCEPHALOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; EPILEPSY; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

EID: 84905593244     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-014-0272-3     Document Type: Article

References (56)

1. Boon P, Vonck K, De Reuck J, Caemaert J. Vagus nerve stimulation for refractory epilepsy. Seizure 2001;10: 448-455.
2. Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol 2002;1: 477-482.
3. George R, Sonnen A, Upton A, et al. A randomized controlled trial of chronic vagus nerve-stimulation for treatment of medically intractable seizures. Neurology 1995;45: 224-230.
4. Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998;51: 48-55.
5. Privitera MD, Welty TE, Ficker DM, Welge J. Vagus nerve stimulation for partial seizures. Cochrane Database Syst Rev 2002: CD002896.
6. Vonck K, Boon P, D'Have N, Vandekerckhove T, O'Connor S, de Reuck J. Long-term results of vagus nerve stimulation in refractory epilepsy. Seizure 1999;8: 328-334.
7. DeGiorgio CM, Schachter SC, Handforth A, et al. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia 2000;41: 1195-1200.
8. De Herdt V, Boon P, Ceulemans B, et al. Vagus nerve stimulation for refractory epilepsy: A Belgian multicenter study. Eur J Paediatr Neurol 2007;11: 261-269.
9. Elliott RE, Morsi A, Kalhorn SP, et al. Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: Long-term outcomes and predictors of response. Epilepsy Behav 2011;20: 57-63.
10. Englot DJ, Chang EF, Auguste KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response A review. J Neurosurg 2011;115: 1248-1255.
11. Fornai F, Ruffoli R, Giorgi FS, Paparelli A. The role of locus coeruleus in the antiepileptic activity induced by vagus nerve stimulation. Eur J Neurosci 2011;33: 2169-2178.
12. Raedt R, Clinckers R, Mollet L, et al. Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model. J Neurochem 2011;117: 461-469.
13. Polich J. Updating p300: An integrative theory of P3a and P3b. Clin Neurophysiol 2007;118: 2128-2148.
14. Duncan CC, Barry RJ, Connolly JF, et al. Event-related potentials in clinical research: Guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. Clin Neurophysiol 2009;120: 1883-1908.
15. Nieuwenhuis S, Aston-Jones G, Cohen JD. Decision making, the p3, and the locus coeruleus-norepinephrine system. Psychol Bull 2005;131: 510-532.
16. Murphy PR, Robertson IH, Balsters JH, O'Connell R G. Pupillometry and P3 index the locus coeruleus-noradrenergic arousal function in humans. Psychophysiology 2011;48: 1532-1543.
17. Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 2003;42: 33-84.
18. Sara SJ. The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 2009;10: 211-223.
19. Nieuwenhuis S, De Geus EJ, Aston-Jones G. The anatomical and functional relationship between the P3 and autonomic components of the orienting response. Psychophysiology 2011;48: 162-175.
20. Aston-Jones G, Cohen JD. An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci 2005;28: 403-450.
21. Pineda JA, Foote SL, Neville HJ. Effects of locus coeruleus lesions on auditory, long-latency, event-related potentials in monkey. J Neurosci 1989;9: 81-93.
22. Boon P, De Herdt V, Vonck K, van Roost D. Clinical experience with vagus nerve stimulation and deep brain stimulation in epilepsy. Acta Neurochir Suppl 2007;97: 273-280.
23. Shahwan A, Bailey C, Maxiner W, Harvey AS. Vagus nerve stimulation for refractory epilepsy in children: More to VNS than seizure frequency reduction. Epilepsia 2009;50: 1220-1228.
24. Picton TW, Bentin S, Berg P, et al. Guidelines for using human event-related potentials to study cognition: Recording standards and publication criteria. Psychophysiology 2000;37: 127-152.
25. Luck SJ. An introduction to the event-related potential technique. MIT Press, Harvard, MA, 2005.
26. Kappenman ES, Kaiser ST, Robinson BM, et al. Response activation impairments in schizophrenia: Evidence from the lateralized readiness potential. Psychophysiology 2012;49: 73-84.
27. Luck SJ, Mathalon DH, O'Donnell BF, et al. A roadmap for the development and validation of event-related potential biomarkers in schizophrenia research. Biol Psychiatry 2011;70: 28-34.
28. Frodl T, Meisenzahl EM, Muller D, et al. The effect of the skull on event-related P300. Clin Neurophysiol 2001;112: 1773-1776.
29. Ahlfors SP, Han J, Lin FH, et al. Cancellation of EEG and MEG signals generated by extended and distributed sources. Hum Brain Mapp 2010;31: 140-149.
30. Hammond EJ, Uthman BM, Reid SA, Wilder BJ. Electrophysiologic studies of cervical vagus nerve stimulation in humans: II. Evoked potentials. Epilepsia 1992;33: 1021-1028.
31. Enoki H, Sanada S, Oka E, Ohtahara S. Event-related potentials in epileptic children treated with monotherapy. J Epilepsy 1995;8: 219-226.
32. Meador KJ, Loring DW, Moore EE, et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology 1995;45: 1494-1499.
33. Kubota F, Kifune A, Shibata N, Akata T, Takeuchi K, Takahashi S. Study on the P300 of adult epileptic patients (unmedicated and medicated patients). J Epilepsy 1998;11: 325-331.
34. Brázdil M, Chadim P, Daniel P, et al. Effect of vagal nerve stimulation on auditory and visual event-related potentials. Eur J Neurol 2001;8: 457-461.
35. Caravaglios G, Natale E, Ferraro G, Fierro B, Raspanti G, Daniele O. Auditory event-related potentials (P300) in epileptic patients. Neurophysiol Clin 2001;31: 121-129.
36. Neuhaus AH, Luborzewski A, Rentzsch J, et al. P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder. J Affect Disorders 2007;100: 123-128.
37. Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 2000;42: 203-210.
38. Harden CL, Pulver MC, Ravdin LD, Nikolov B, Halper JP, Labar DR. A Pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 2000;1: 93-99.
39. Nahas Z, Marangell LB, Husain MM, et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 2005;66: 1097-1104.
40. Daban C, Martinez-Aran A, Cruz N, Vieta E. Safety and efficacy of vagus nerve stimulation in treatment-resistant depression. A systematic review. J Affect Disorders 2008;110: 1-15.
41. Kanner A, Schachter SC. Psychiatric controversies in epilepsy. Elsevier Science, Academic Press, Amsterdam, The Netherlands, 2010.
42. Kanner AM. Depression and epilepsy: A bidirectional relation? Epilepsia 2011;52: 21-27.
43. Jobe PC. Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy Behav 2003;4: S14-S24.
44. van Bockstaele EJ, Peoples J, Telegan P. Efferent projections of the nucleus of the solitary tract to peri-locus coeruleus dendrites in rat brain: Evidence for a monosynaptic pathway. J Comp Neurol 1999;412: 410-428.
45. Groves DA, Bowman EM, Brown VJ. Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat. Neurosci Lett 2005;379: 174-179.
46. Dorr AE, Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmacol Exp Ther 2006;318: 890-898.
47. Roosevelt RW, Smith DC, Clough RW, Jensen RA, Browning RA. Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat. Brain Res 2006;1119: 124-132.
48. Hassert DL, Miyashita T, Williams CL. The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala. Behav Neurosci 2004;118: 79-88.
49. Follesa P, Biggio F, Gorini G, et al. Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain. Brain Res 2007;1179: 28-34.
50. Krahl SE, Clark KB, Smith DC, Browning RA. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 1998;39: 709-714.
51. Clark KB, Naritoku DK, Smith DC, Browning RA, Jensen RA. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat Neurosci 1999;2: 94-98.
52. Aldenkamp AP, Majoie HJM, Berfelo MW, et al. Long-term effects of 24-month treatment with vagus nerve stimulation on behaviour in children with Lennox-Gastaut syndrome. Epilepsy Behav 2002;3: 475-479.
53. Sackeim HA, Keilp JG, Rush AJ, et al. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry Neuropsychol Behave Neurol 2001;14: 53-62.
54. Sjogren MJC, Hellstrom PTO, Jonsson MAG, Runnerstam M, Silander HC, Ben-Menachem E. Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: A pilot study. J Clin Psychiat 2002;63: 972-980.
55. Sara SJ, Bouret S. Orienting and reorienting: The locus coeruleus mediates cognition through arousal. Neuron 2012;76: 130-141.
56. Stefan H, Kreiselmeyer G, Kerling F, et al. Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial. Epilepsia 2012;53: e115-e118.